Constarium
← Search

Data · dataset · 2014

Reanalysis of JUPITER clinical trial (NCT00239681)- Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

Listed in DataCite

Table: Reanalysis of adverse events NCT00239681: JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events Chi-square statistics ______ 1.

Description

Not all adverse drug reactions are included in this Table. 2. Adverse events appear to be much higher than 18%.

(1) 3. Results available at ClinicalTrials.gov for the JUPITER study are not consistent with publications reporting the results of this trial. ncbi.nlm.nih.gov/pubmed/?term=NCT00239681 For example: - Discordance between results reported in the number of patients diagnosed with diabetes mellitus. 1. ClinicalTrials.gov: Placebo=13; Rosuvastatin=14 | 2.

Read the rest (3 more)

Article (PMID: 22883507): Placebo=216; Rosuvastatin=270) 4. Primary outcome was modified in the registry history available at ClinicalTrials.gov clinicaltrials.gov/archive/NCT00239681/2014_03_21/changes 5. It is not clear why the study was terminated.

March 13, 2008. "Independent Data Monitoring Committee for JUPITER met and agreed that the studyshould continue as planned." April 2, 2008. "AstraZeneca announced it has decided to stop the CRESTOR JUPITER clinicalstudy early based on a recommendation from an Independent Data Monitoring Boardand the JUPITER Steering Committee, which met on March 29, 2008. The study willbe stopped early because there is unequivocal evidence of a reduction incardiovascular morbidity and mortality amongst patients who received CRESTOR when compared to placebo." clinicaltrials.gov/archive/NCT00239681/2008_04_02/changes References 1.

Should people at low risk of cardiovascular disease take a statin? BMJ 2014; 348:g3329

Links

Topics

Stated by source
Mathematics
Inferred from text
Cardiovascular disease 75% · Disease 75% · Tabular 65%

Related

Provenance · 1 source records, 14 field assertions
SourceKeyLast seenRaw
DataCite10.6084/m9.figshare.1100173.v411 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · DataCiteconnector:datacite@1.0.0/data/attributes/rightsList
byte_sizesource · DataCiteconnector:datacite@1.0.0
concepts[disease].local:disease:cardiovascular-diseaseenrichment · DataCitekeyword-concept-rules@1.0.0title+description (75%)
concepts[disease].local:disease:diseaseenrichment · DataCitekeyword-concept-rules@1.0.0title+description (75%)
concepts[field].fos:mathematicssource · DataCiteconnector:datacite@1.0.0
concepts[field].local:field:mathematics-statisticsmapping · DataCitevocabulary-mapper@1.0.0keywords['Statistics']
concepts[field].local:field:medicine-healthmapping · DataCitevocabulary-mapper@1.0.0keywords['Medicine']
concepts[modality].local:modality:tabularenrichment · DataCitekeyword-concept-rules@1.0.0title+description (65%)
created_datesource · DataCiteconnector:datacite@1.0.0
descriptionsource · DataCiteconnector:datacite@1.0.0/data/attributes/descriptions
licensesource · DataCiteconnector:datacite@1.0.0/data/attributes/rightsList
publication_datesource · DataCiteconnector:datacite@1.0.0/data/attributes/dates
titlesource · DataCiteconnector:datacite@1.0.0/data/attributes/titles/0/title
updated_datesource · DataCiteconnector:datacite@1.0.0